LivaNova (LIVN) EBITDA Margin (QoQ) (2015 - 2026)
Analysis
LivaNova (LIVN) EBITDA Margin (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.41 Bn | 175.81 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.42 Bn | 122.20 Bn | 1.96 Bn |
| 3 | Medtronic | 117.31 Bn | 108.49 Bn | 6.34 Bn |
| 4 | Stryker | 105.19 Bn | 101.72 Bn | 4.50 Bn |
| 5 | Boston Scientific | 64.84 Bn | 64.30 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.86 Bn | 45.61 Bn | 1.35 Bn |
| 7 | Alcon | 33.12 Bn | 31.66 Bn | 1.68 Bn |
| 8 | Dexcom | 32.09 Bn | 30.15 Bn | 830.00 Mn |
| 9 | Steris | 20.72 Bn | 20.24 Bn | 684.20 Mn |
| 10 | LivaNova | 4.30 Bn | 3.78 Bn | 273.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 122.00 |
| Mar 31, 2026 | -35.00 |
| Dec 31, 2025 | -330.00 |
| Sep 30, 2025 | -27.00 |
| Jun 30, 2025 | 3.00 |
| Mar 31, 2025 | 384.00 |
| Dec 31, 2024 | 31.00 |
| Sep 30, 2024 | -141.00 |
| Jun 30, 2024 | 710.00 |
| Mar 31, 2024 | 3,388.00 |
| Dec 31, 2023 | -2,993.00 |
| Sep 30, 2023 | -435.00 |
| Jun 30, 2023 | 680.00 |
| Mar 31, 2023 | -597.00 |
| Dec 31, 2022 | 5,732.00 |
| Sep 30, 2022 | -6,474.00 |
| Jun 30, 2022 | 854.00 |
| Mar 31, 2022 | -521.00 |
| Dec 31, 2021 | 268.00 |
| Sep 30, 2021 | 2,020.00 |